- Investing Ideas
- /
- Indian Pharmaceuticals & Biotech Potentially Undervalued Companies
Indian Pharmaceuticals & Biotech Potentially Undervalued Companies
UPDATED Sep 27, 2023
Companies with a Value score of at least 3, ordered by Value score
55 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 543635Piramal Pharma | ₹96.85 | -3.0% | n/a | ₹128.1b | ₹126.50 | PS1.7x | E86.8% | 0% | ||
| 541540Solara Active Pharma Sciences | ₹356.85 | -0.3% | -14.0% | ₹12.8b | ₹421.46 | PB0.9x | E113.3% | 0% | ||
| 524816NATCO Pharma | ₹879.40 | 1.2% | 46.7% | ₹157.4b | ₹809.63 | PE19.3x | E22.6% | 0.6% | ||
| SOLARASolara Active Pharma Sciences | ₹355.90 | -0.5% | -14.2% | ₹12.8b | ₹420.33 | PB0.9x | E113.3% | 0% | ||
| 532531Strides Pharma Science | ₹515.35 | 5.7% | 60.7% | ₹46.6b | ₹619.01 | PS1.3x | E116.5% | 0.3% | ||
| PPLPHARMAPiramal Pharma | ₹96.85 | -2.9% | n/a | ₹128.1b | ₹126.50 | PS1.7x | E86.8% | 0% | ||
| STARStrides Pharma Science | ₹515.90 | 5.7% | 61.0% | ₹46.6b | ₹619.67 | PS1.3x | E116.5% | 0.3% | ||
| NATCOPHARMNATCO Pharma | ₹878.90 | 1.2% | 46.5% | ₹157.4b | ₹809.17 | PE19.3x | E22.6% | 0.6% | ||
| 524414Norris Medicines | ₹11.70 | 0% | -28.2% | ₹117.0m | n/a | PS1.4x | n/a | n/a | ||
| VENUSREMVenus Remedies | ₹251.40 | 8.1% | 24.9% | ₹3.3b | ₹308.35 | PE16x | n/a | 0% | ||
| 532649Nectar Lifesciences | ₹24.96 | -0.7% | 20.0% | ₹5.6b | n/a | PB0.5x | n/a | 0% | ||
| 506128Parnax Lab | ₹85.76 | -5.1% | 12.4% | ₹985.0m | n/a | PE9.8x | n/a | n/a | ||
| MANGALAMMangalam Drugs & Organics | ₹102.75 | 1.3% | -28.4% | ₹1.6b | n/a | PB1.1x | n/a | 0% | ||
| 524348Aarti Drugs | ₹547.00 | -5.6% | 22.4% | ₹50.3b | ₹620.00 | PE28x | E35.7% | 0.2% | ||
| 506260Anuh Pharma | ₹131.05 | 0.5% | 43.5% | ₹6.6b | n/a | PE16.2x | n/a | 1.5% | ||
| 532637Mangalam Drugs & Organics | ₹102.55 | 1.0% | -28.5% | ₹1.6b | n/a | PB1.1x | n/a | 0% | ||
| 524652Ind-Swift | ₹19.99 | -9.5% | 114.9% | ₹1.1b | n/a | PE2.5x | n/a | 0% | ||
| INDSWFTLTDInd-Swift | ₹20.30 | -9.2% | 114.8% | ₹1.1b | n/a | PE2.5x | n/a | 0% | ||
| 526953Venus Remedies | ₹250.30 | 7.3% | 23.6% | ₹3.3b | ₹307.00 | PE16x | n/a | 0% | ||
| 524606Beryl Drugs | ₹20.83 | -5.0% | 125.2% | ₹105.6m | n/a | PE9.8x | n/a | n/a | ||
| 524506Coral Laboratories | ₹286.75 | 3.0% | 14.7% | ₹1.0b | n/a | PE15.3x | n/a | 0% | ||
| 532305Ind-Swift Laboratories | ₹88.95 | 0.6% | 59.8% | ₹5.3b | n/a | PE11.7x | n/a | n/a | ||
| INDSWFTLABInd-Swift Laboratories | ₹89.15 | 1.0% | 59.9% | ₹5.3b | n/a | PE11.7x | n/a | n/a | ||
| 506414Fermenta Biotech | ₹165.40 | -2.5% | -20.2% | ₹4.8b | n/a | PS1.4x | n/a | 0.8% |